Peerview Oncology

Optimal SCLC Care With Established and Innovative Therapies 01:27:09
Optimal SCLC Care With Established and Innovative Therapies PeerView Oncology 437 4 месяца назад
Advances in Endometrial Carcinoma Treatment: The Power of Immunotherapy and Other Emerging Regimens 49:39
Advances in Endometrial Carcinoma Treatment: The Power of Immunotherapy and Other Emerging Regimens PeerView Oncology 681 4 месяца назад
Deep Insight Into Immuno-Oncology: Immunotherapy Pathways, Targets, and Biomarkers 01:03:39
Deep Insight Into Immuno-Oncology: Immunotherapy Pathways, Targets, and Biomarkers PeerView Oncology 79,016 4 года назад
Elevating Care in Resectable Stage I-III NSCLC 01:03:31
Elevating Care in Resectable Stage I-III NSCLC PeerView Oncology 368 2 месяца назад
The Collaborative Benchmark for HCC: Critical Discussions Between IR–Oncology Professionals 57:49
The Collaborative Benchmark for HCC: Critical Discussions Between IR–Oncology Professionals PeerView Oncology 423 5 месяцев назад
Advancing Personalized Care in RCC 01:29:00
Advancing Personalized Care in RCC PeerView Oncology 358 9 месяцев назад
Collaborative Care and Next Steps With Adjuvant and Neoadjuvant Immunotherapy for Melanoma 01:23:36
Collaborative Care and Next Steps With Adjuvant and Neoadjuvant Immunotherapy for Melanoma PeerView Oncology 522 7 месяцев назад
Making Precision Decisions in High-Risk HR+, HER2- Metastatic Breast Cancer 59:12
Making Precision Decisions in High-Risk HR+, HER2- Metastatic Breast Cancer PeerView Oncology 400 2 месяца назад
Decoding Biomarker Testing and Targeted Therapy in NSCLC 01:25:15
Decoding Biomarker Testing and Targeted Therapy in NSCLC PeerView Oncology 512 5 месяцев назад
Capitalizing on HER2-Targeted Regimens to Improve Outcomes for Gastric/GEJ Cancers, CRC, and BTC 01:22:29
Capitalizing on HER2-Targeted Regimens to Improve Outcomes for Gastric/GEJ Cancers, CRC, and BTC PeerView Oncology 383 5 месяцев назад
Guiding Multifactorial Clinical Decisions in HR+, HER2- Breast Cancer 01:24:52
Guiding Multifactorial Clinical Decisions in HR+, HER2- Breast Cancer PeerView Oncology 373 54 года назад
Watch Dr. Ramalingam discuss the latest #NSCLC updates from #WCLC24 - https://bit.ly/24Stage3LungY 01:01:05
Watch Dr. Ramalingam discuss the latest #NSCLC updates from #WCLC24 - https://bit.ly/24Stage3LungY PeerView Oncology 332 2 месяца назад
Mastering the Art of Precision in the Treatment of HR+ Early and Metastatic Breast Cancer 01:25:24
Mastering the Art of Precision in the Treatment of HR+ Early and Metastatic Breast Cancer PeerView Oncology 1,218 10 месяцев назад
REVIVE Initiative: Reinforcing Evidence-Based Principles Against Cancer-Associated VTE 36:08
REVIVE Initiative: Reinforcing Evidence-Based Principles Against Cancer-Associated VTE PeerView Oncology 208 8 месяцев назад
Watch Dr. Liu discuss #NSCLC updates from #ASCO24 - https://bit.ly/2024BiomarkersY 01:38:45
Watch Dr. Liu discuss #NSCLC updates from #ASCO24 - https://bit.ly/2024BiomarkersY PeerView Oncology 1,317 5 месяцев назад
Navigating the Expanding Treatment Arsenal for ER+/HER2- Breast Cancer 57:18
Navigating the Expanding Treatment Arsenal for ER+/HER2- Breast Cancer PeerView Oncology 2,891 2 года назад
Catalysts for Change in Gastric & GEJ Cancer 01:35:13
Catalysts for Change in Gastric & GEJ Cancer PeerView Oncology 473 5 месяцев назад
Unlocking the Power of Modern Therapeutic Regimens for Prostate Cancer 01:32:31
Unlocking the Power of Modern Therapeutic Regimens for Prostate Cancer PeerView Oncology 841 5 месяцев назад
Maximizing the of Potential Current and Emerging Immunotherapies in Advanced Endometrial Cancer 33:06
Maximizing the of Potential Current and Emerging Immunotherapies in Advanced Endometrial Cancer PeerView Oncology 1,967 2 года назад
#Glioma updates from #SNO led by Drs. Ahluwalia & Wen - https://bit.ly/2024GliomaY 01:02:31
#Glioma updates from #SNO led by Drs. Ahluwalia & Wen - https://bit.ly/2024GliomaY PeerView Oncology 56 6 дней назад

Сейчас ищут